Relugolix, A Novel Oral GnRH Receptor Antagonist, versus Leuprolide Depot for Prostate Cancer: The HERO Phase 3 Trial

被引：0
|
作者：
Spratt, D. E. [1 ]
Shore, N. [2 ]
Bossi, A. [3 ]
van Veenhuyzen, D. [4 ]
Selby, B. [4 ]
Kang, V. [4 ]
Dearnaley, D. [5 ]
机构：
[1] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA
[2] Carolina Urol Res Ctr, Myrtle Beach, SC USA
[3] Inst Gustave Roussy, Dept Radiat Oncol, Villejuif, France
[4] Myovant Sci Inc, Brisbane, AA USA
[5] Royal Marsden Hosp, Inst Canc Res, London, England
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2020年 / 108卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
35
引用
收藏
页码：S18 / S19
页数：2
相关论文
共 50 条
  • [1] HERO PHASE 3 TRIAL: RESULTS COMPARING RELUGOLIX, AN ORAL GNRH RECEPTOR ANTAGONIST, VS LEUPROLIDE ACETATE FOR ADVANCED PROSTATE CANCER
    Shore, Neal
    Saad, Fred
    Cookson, Michael
    George, David J.
    Saltzstein, Daniel R.
    Tutrone, Ronald
    Akaza, Hideyuki
    Bossi, Alberto
    van Veenhuyzen, David
    Selby, Bryan
    Fan, Xiaolin
    Kang, Vicky
    Walling, Jackie
    Tombal, Bertrand
    JOURNAL OF UROLOGY, 2020, 203 : E1117 - E1117
  • [2] HERO phase III trial: Results comparing relugolix, an oral GnRH receptor antagonist, versus leuprolide acetate for advanced prostate cancer.
    Shore, Neal D.
    George, Daniel J.
    Saad, Fred
    Cookson, Michael
    Saltzstein, Daniel R.
    Tutrone, Ronald F.
    Akaza, Hideyuki
    Bossi, Alberto
    van Veenhuyzen, David
    Selby, Bryan
    Fan, Xiaolin
    Kang, Vicky
    Walling, Jacqueline M.
    Tombal, Bertrand F.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [3] Phase 3 HERO Trial Finds Relugolix to Be Superior to Leuprolide in Prostate Cancer
    Slater, Hannah
    ONCOLOGY-NEW YORK, 2020, 34 (07): : 252 - 253
  • [4] Relugolix as a promising novel oral GnRH antagonist for prostate cancer treatment
    Lv, Jialu
    Lin, Jianqing
    ASIAN JOURNAL OF ANDROLOGY, 2021, 23 (03) : 229 - 230
  • [5] Testosterone Recovery for Relugolix Versus Leuprolide in Men with Advanced Prostate Cancer: Results from the Phase 3 HERO Study
    Tutrone, Ronald
    Saad, Fred
    George, Daniel J.
    Tombal, Bertrand
    Bailen, James L.
    Cookson, Michael S.
    Saltzstein, Daniel R.
    Hanson, Sarah
    Brown, Bruce
    Lu, Sophia
    Fallick, Mark
    Shore, Neal D.
    EUROPEAN UROLOGY ONCOLOGY, 2024, 7 (04): : 906 - 913
  • [6] Impact of Relugolix Versus Leuprolide on the Quality of Life of Men with Advanced Prostate Cancer: Results from the Phase 3 HERO Study
    Tombal, Bertrand
    Collins, Sean
    Morgans, Alicia K.
    Hunsche, Elke
    Brown, Bruce
    Zhu, Emily
    Bossi, Alberto
    Shore, Neal
    EUROPEAN UROLOGY, 2023, 84 (06) : 579 - 587
  • [7] Testosterone recovery for relugolix versus leuprolide in men with advanced prostate cancer: Results from the phase 3 HERO study.
    Tutrone, Ronald F.
    Saad, Fred
    George, Daniel J.
    Tombal, Bertrand F.
    Bailen, James L.
    Cookson, Michael
    Saltzstein, Daniel
    Brown, Bruce
    Lu, Sophia
    Shore, Neal D.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [8] Re: Impact of Relugolix Versus Leuprolide on the Quality of Life of Men with Advanced Prostate Cancer: Results from the Phase 3 HERO Study
    Di Lorenzo, Giuseppe
    Buonerba, Carlo
    EUROPEAN UROLOGY, 2025, 87 (01) : 92 - 93
  • [9] Efficacy and safety of relugolix in black men with advanced prostate cancer: A subgroup analysis from the randomized, phase 3 HERO study versus leuprolide.
    George, Daniel J.
    Saad, Fred
    Pieczonka, Christopher Michael
    Cookson, Michael
    Saltzstein, Daniel
    Tutrone, Ronald F.
    Brown, Bruce
    Lu, Sophia
    Fallick, Mark
    Hanson, Sarah
    Shore, Neal D.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [10] Impact of age on efficacy and safety of relugolix: A subgroup analysis from the randomized, phase 3 hero study versus leuprolide in men with advanced prostate cancer.
    Cookson, Michael
    Shore, Neal D.
    George, Daniel J.
    Akaza, Hideyuki
    Saltzstein, Daniel
    Tutrone, Ronald F.
    Bossi, Alberto
    Brown, Bruce
    Selby, Bryan
    Lu, Sophia
    Walling, Jacqueline M.
    Tombal, Bertrand F.
    Saad, Fred
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345